<DOC>
	<DOC>NCT00767481</DOC>
	<brief_summary>Parallel, Multi-Center, Double-masked, Active controlled, three arm study comparing the IOP lowering efficacy and safety over 12 months of morning or evening instillations of Travoprost/Brinzolamide vs. Cosopt dosed in the morning and evening in patients with open-angle glaucoma or ocular hypertension.</brief_summary>
	<brief_title>1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Travoprost</mesh_term>
	<mesh_term>Brinzolamide</mesh_term>
	<criteria>IOP at screening visit &lt;18mmHg in at least one eye Mean IOP in same eye (at both eligibility 1 &amp;2 visits) 24 and ≤ 36 mmHg at 9:00 21 and ≤ 36 mmHg at 11:00 and 16:00 Severe central visual field loss Angle Shaffer grade &lt; 2 C/D ratio &gt; 0.8 (horizontal or vertical measurement)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>glaucoma</keyword>
	<keyword>Patients with open-angle glaucoma or ocular hypertension</keyword>
</DOC>